Long-term impairment of lung clearance is observed after initial infection with influenza A virus but not human metapneumovirus in mice Free

Abstract

Human metapneumovirus (hMPV) is a paramyxovirus responsible for respiratory tract infections in humans. Our objective was to investigate whether hMPV could predispose to long-term bacterial susceptibility, such as previously observed with influenza viruses. BALB/c mice were infected with hMPV or influenza A and, 14 days following viral infection, challenged with . Only mice previously infected with influenza A demonstrated an 8 % weight loss of their body weight 72 h following infection, which correlated with an enhanced lung bacterial replication of >7 log compared with pneumococcus infection alone. This enhanced bacterial replication was not related to altered macrophage or neutrophil recruitment or deficient production of critical cytokines. However, bacterial challenge induced the production of gamma interferon in bronchoalveolar lavages of influenza-infected mice, but not in those of hMPV-infected animals. In conclusion, hMPV does not cause long-term impairment of pneumococcus lung clearance, in contrast to influenza A virus.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.030825-0
2011-07-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jgv/92/7/1662.html?itemId=/content/journal/jgv/10.1099/vir.0.030825-0&mimeType=html&fmt=ahah

References

  1. Abed Y., Baz M., Boivin G. 2006; Impact of neuraminidase mutations conferring influenza resistance to neuraminidase inhibitors in the N1 and N2 genetic backgrounds. Antivir Ther 11:971–976[PubMed]
    [Google Scholar]
  2. Boivin G., Abed Y., Pelletier G., Ruel L., Moisan D., Côté S., Peret T. C., Erdman D. D., Anderson L. J. 2002; Virological features and clinical manifestations associated with human metapneumovirus: a new paramyxovirus responsible for acute respiratory-tract infections in all age groups. J Infect Dis 186:1330–1334 [View Article][PubMed]
    [Google Scholar]
  3. Didierlaurent A., Goulding J., Patel S., Snelgrove R., Low L., Bebien M., Lawrence T., van Rijt L. S., Lambrecht B. N. et al. 2008; Sustained desensitization to bacterial Toll-like receptor ligands after resolution of respiratory influenza infection. J Exp Med 205:323–329 [View Article][PubMed]
    [Google Scholar]
  4. Hamelin M. E., Côté S., Laforge J., Lampron N., Bourbeau J., Weiss K., Gilca R., DeSerres G., Boivin G. 2005a; Human metapneumovirus infection in adults with community-acquired pneumonia and exacerbation of chronic obstructive pulmonary disease. Clin Infect Dis 41:498–502 [View Article][PubMed]
    [Google Scholar]
  5. Hamelin M. E., Yim K., Kuhn K. H., Cragin R. P., Boukhvalova M., Blanco J. C., Prince G. A., Boivin G. 2005b; Pathogenesis of human metapneumovirus lung infection in BALB/c mice and cotton rats. J Virol 79:8894–8903 [View Article][PubMed]
    [Google Scholar]
  6. Klein M. B., Yang H., DelBalso L., Carbonneau J., Frost E., Boivin G. 2010; Viral pathogens including human metapneumovirus are the primary cause of febrile respiratory illness in HIV-infected adults receiving antiretroviral therapy. J Infect Dis 201:297–301 [View Article][PubMed]
    [Google Scholar]
  7. Kukavica-Ibrulj I., Hamelin M. E., Prince G. A., Gagnon C., Bergeron Y., Bergeron M. G., Boivin G. 2009; Infection with human metapneumovirus predisposes mice to severe pneumococcal pneumonia. J Virol 83:1341–1349 [View Article][PubMed]
    [Google Scholar]
  8. Madhi S. A., Klugman K. P.The Vaccine Trialist Group 2004; A role for Streptococcus pneumoniae in virus-associated pneumonia. Nat Med 10:811–813 [View Article][PubMed]
    [Google Scholar]
  9. Madhi S. A., Ludewick H., Kuwanda L., Niekerk N., Cutland C., Little T., Klugman K. P. 2006; Pneumococcal coinfection with human metapneumovirus. J Infect Dis 193:1236–1243 [View Article][PubMed]
    [Google Scholar]
  10. McNamee L. A., Harmsen A. G. 2006; Both influenza-induced neutrophil dysfunction and neutrophil-independent mechanisms contribute to increased susceptibility to a secondary Streptococcus pneumoniae infection. Infect Immun 74:6707–6721 [View Article][PubMed]
    [Google Scholar]
  11. Peltola V. T., McCullers J. A. 2004; Respiratory viruses predisposing to bacterial infections: role of neuraminidase. Pediatr Infect Dis J 23:Suppl.S87–S97 [View Article][PubMed]
    [Google Scholar]
  12. Shahangian A., Chow E. K., Tian X., Kang J. R., Ghaffari A., Liu S. Y., Belperio J. A., Cheng G., Deng J. C. 2009; Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice. J Clin Invest 119:1910–1920 [View Article][PubMed]
    [Google Scholar]
  13. Speshock J. L., Doyon-Reale N., Rabah R., Neely M. N., Roberts P. C. 2007; Filamentous influenza A virus infection predisposes mice to fatal septicemia following superinfection with Streptococcus pneumoniae serotype 3. Infect Immun 75:3102–3111 [View Article][PubMed]
    [Google Scholar]
  14. Sun K., Metzger D. W. 2008; Inhibition of pulmonary antibacterial defense by interferon-gamma during recovery from influenza infection. Nat Med 14:558–564 [View Article][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.030825-0
Loading
/content/journal/jgv/10.1099/vir.0.030825-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed